Why are tacrolimus levels checked so often?

Tacrolimus has a narrow window: too low invites rejection, too high injures the kidney and raises blood sugar. Trough levels let the team tune the dose precisely — typically 8-12 ng/mL early after transplant, lower in maintenance.

Can I take grapefruit with tacrolimus?

No — grapefruit and pomegranate significantly raise tacrolimus levels and must be avoided entirely while on the drug.

Does tacrolimus damage kidneys?

It can — calcineurin nephrotoxicity is its main long-term limitation, which is exactly why levels are monitored and doses tuned to the smallest effective amount.

Calcineurin inhibitor (immunosuppressant)

Tacrolimus and Kidneys

Brand names: Prograf / Envarsus XR / Astagraf XL • Drug class: Calcineurin inhibitor (immunosuppressant)

Tacrolimus is the backbone immunosuppressant after kidney transplant — it quiets the T-cells that would attack the new kidney, and its blood levels are tuned like a dose dial. It is also used in selected autoimmune kidney diseases (lupus nephritis, membranous nephropathy) as a steroid-sparing agent.

How it affects the kidneys

Tacrolimus makes transplant possible, but it has a kidney cost: calcineurin toxicity can injure the kidney itself, and it commonly raises blood pressure and blood sugar. That is why trough levels are monitored closely and doses are kept at the smallest effective level — the balance between rejection and toxicity is the art of transplant care.

Evidence at a glance

Tacrolimus-based regimens are the standard of care in kidney transplantation, with level-guided dosing reducing both rejection and nephrotoxicity

Transplant immunosuppression trials, 1990s-present

Trough-level monitoring (targets ~8-12 ng/mL early, lower in maintenance) is associated with better graft outcomes

Transplant level-monitoring literature, 2000s-present

Non-adherence to immunosuppression is the leading preventable cause of late graft loss

Adherence research, 2010s-present

Renal dosing guidance

Dosed by blood trough levels and clinical response — not by eGFR alone. In kidney impairment, levels are tuned to avoid calcineurin nephrotoxicity. Grapefruit and pomegranate must be avoided (they raise levels).

Check your kidney function

Key warnings

Kidney toxicity (calcineurin nephrotoxicity) — the main long-term limitation; level monitoring is mandatory
New-onset or worsening diabetes — glucose is checked regularly
Tremor, headache, and neurological side effects
Interactions: azole antifungals, macrolide antibiotics, and some calcium-channel blockers raise levels — every new prescription needs a pharmacy check
Never stop or change the dose on your own — even during illness

Sources

KDIGO 2020 Clinical Practice Guideline on Evaluation and Management of Candidates for Kidney Transplantation
Prograf prescribing information
Transplant immunosuppression trial literature

This page is educational. Medication decisions — especially dosing changes — must be made by your prescribing clinician.

Tacrolimus: Common Questions

Kidney Function & eGFR

eGFR calculator (CKD-EPI 2021)eGFR decline & time-to-failure estimator Creatinine 1.3 — is it normal?eGFR 45 — what it means What is eGFR?Can kidney disease be reversed?

Diabetes & Kidney Protection

Ozempic (semaglutide) & kidneys SGLT2 inhibitors explained Metformin & kidney function Metformin eligibility checker Does diabetes always cause kidney failure?Kidney health risk screener

Related Drugs & Kidneys

Semaglutide (Ozempic, Wegovy) and Kidneys

Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and obesity. The FLOW trial (NEJM 2024) showe…

Learn more

SGLT2 Inhibitors (Dapagliflozin, Empagliflozin) and Kidneys

SGLT2 inhibitors — originally diabetes drugs — are now a cornerstone of kidney disease treatment. DAPA-CKD and…

Learn more

Dapagliflozin (Farxiga/Forxiga) and Kidneys

Dapagliflozin is the first SGLT2 inhibitor proven to protect kidneys in CKD with and without diabetes (DAPA-CK…

Learn more

Empagliflozin (Jardiance) and Kidneys

Empagliflozin is an SGLT2 inhibitor approved for CKD with albuminuria (eGFR ≥20) and heart failure. The EMPA-K…

Learn more

Calcineurin inhibitor (immunosuppressant)

Tacrolimus and Kidneys

Brand names: Prograf / Envarsus XR / Astagraf XL • Drug class: Calcineurin inhibitor (immunosuppressant)

How it affects the kidneys

Evidence at a glance

Tacrolimus-based regimens are the standard of care in kidney transplantation, with level-guided dosing reducing both rejection and nephrotoxicity

Transplant immunosuppression trials, 1990s-present

Trough-level monitoring (targets ~8-12 ng/mL early, lower in maintenance) is associated with better graft outcomes

Transplant level-monitoring literature, 2000s-present

Non-adherence to immunosuppression is the leading preventable cause of late graft loss

Adherence research, 2010s-present

Renal dosing guidance

Check your kidney function

Key warnings

Kidney toxicity (calcineurin nephrotoxicity) — the main long-term limitation; level monitoring is mandatory
New-onset or worsening diabetes — glucose is checked regularly
Tremor, headache, and neurological side effects
Interactions: azole antifungals, macrolide antibiotics, and some calcium-channel blockers raise levels — every new prescription needs a pharmacy check
Never stop or change the dose on your own — even during illness

Sources

KDIGO 2020 Clinical Practice Guideline on Evaluation and Management of Candidates for Kidney Transplantation
Prograf prescribing information
Transplant immunosuppression trial literature

This page is educational. Medication decisions — especially dosing changes — must be made by your prescribing clinician.

Tacrolimus: Common Questions

Kidney Function & eGFR

eGFR calculator (CKD-EPI 2021)eGFR decline & time-to-failure estimator Creatinine 1.3 — is it normal?eGFR 45 — what it means What is eGFR?Can kidney disease be reversed?

Diabetes & Kidney Protection

Ozempic (semaglutide) & kidneys SGLT2 inhibitors explained Metformin & kidney function Metformin eligibility checker Does diabetes always cause kidney failure?Kidney health risk screener